Women Bare Breasts for Coppafeel!'s Cancer Awareness Campaign

Several women have described and bared their breasts in one word for cancer awareness charity Coppafeel!'s #whatnormalfeelslike campaign.

The charity did a research which found that women aged between the ages of 18-30 didn't really know how to describe their assets apart from words "big or small," which was the result of sexualisation of boobs, making women think only in terms of size, the Daily Star reported.

Predicting Breast Cancer With a Newer and More Accurate Model
Breast tissue biopsy of women with benign breast disease and individual patient demographic information together help predict the risk of classified breast cancer more accurately.

The charity had come up with the hard-hitting campaign last year, where 7 bare-chested women had a word varying from 'firm' to 'squidgy', 'spongy' and 'bobbly, which best described their breasts, body painted on them.

The campaign, shot by British photographer Rankin, was aimed to normalise and desexualise female breasts, so that women would be comfortable with the language around them again.

Currently, thousands of women have joined in with the campaign on social media and at events and festivals around the country, and their new features 24 of the hundreds of real women who bared their breasts in support, which would appear on billboards across the country over the next month.

Diagnosis of Invasive Breast Cancer at an Early Stage and Survival Varies by Race and Ethnicity
The likelihood of diagnosing invasive breast cancer at an early stage, and survival after stage I diagnosis, varied by race and ethnicity.

Kris Hallenga, who founded CoppaFeel! after being diagnosed with stage 4 breast cancer at the age of 23, said that the response so far was overwhelmingly positive and she felt that proud that women had sincerely embraced it.

Source-ANI

Women With Atypical Hyperplasia at Higher Risk of Breast Cancer
Women with atypical hyperplasia (also known as atypia) are at higher risk of developing breast cancer in future than previously thought.

Combination Therapy Shows Promising Results in Early Stage Breast Cancer
A combination therapy with low-dose chemotherapy with paclitaxel and the targeted drug trastuzumab (Herceptin) showed promising results in women with early stage HER2-positive breast cancer.